Conference Coverage

VIDEO: ACTRIMS Forum focuses on progressive MS

A focus of the 2016 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum is the pathogenic mechanisms involved in...

Video

Barry Singer, MD

At ECTRIMS 2015 in Barcelona, Dr. Singer discussed the initial data set from vsMS, a global survey of patients with MS and their caregivers. The...

Video

Stacey Cofield, PhD, of NARCOMS

At ECTRIMS 2015, Dr. Cofield discussed gender differences in attitudes toward marijuana as a treatment for symptoms of MS.

Video

Mark S. Freedman, HBSc, MSc, MD

Prof. Mark Freedman discusses the valuable role that CSF analysis can have in the diagnosis of multiple sclerosis.

Video

Mark S. Freedman, HBSc, MSc, MD

At the 2015 CMSC Annual Meeting, Prof. Mark Freedman discusses recent trial results for teriflunomide.

Audio

Samuel F. Hunter, MD, PhD

An open-label study indicates that patients with multiple sclerosis may benefit from switching to alemtuzumab.

Video

Riley Bove, MD

Dr. Riley Bove discusses how to counsel patients with multiple sclerosis about issues related to pregnancy.

Video

Gerard Gioia, PhD

At the 67th Annual Meeting of the American Academy of Neurology, Dr. Gerard Gioia discusses the return of youth with concussion to cognitive...

Video

Alasdair Coles, MD

Prof. Coles provides four-year follow-up data from the CARE-MS I and CARE-MS II trials, which showed the durable effect of alemtuzumab.

Video

Amber Salter, PhD, MPH

Dr. Amber Salter discusses data from the NARCOMS patient registry that profile characteristics of switchers from older MS therapies to newer oral...

Pages